Gland Pharma Closes Trading Window for Q2/H1 FY27 Results

Gland Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in effect from Thursday, October 01, 2026, and will remain open 48 hours after the declaration of the Unaudited Financial Results for the quarter and half-year ending September 30, 2026. The specific date for the Board Meeting to approve these financial results will be communicated later. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading.